Heterophile Antibodies

Subscribe to Selected New Research on Heterophile Antibodies

240 relevant articles (2 outcomes, 25 trials/studies) found for this Bio-Agent

Description: Antibodies elicited in a different species from which the antigen originated. These antibodies are directed against a wide variety of interspecies-specific antigens, the best known of which are Forssman, Hanganutziu-Deicher (H-D), and Paul-Bunnell (P-B). Incidence of antibodies to these antigens--i.e., the phenomenon of heterophile antibody response--is useful in the serodiagnosis, pathogenesis, and prognosis of infection and latent infectious states as well as in cancer classification.

Also Known As:

Antibodies, Heterophile; Antibodies, Heterologous; Antibodies, Heterophil; Antibodies, Xenogenic; Forssman Antibody; Heterogenetic Antibodies; Antibody, Forssman; Heterophil Antibodies; Heterotypic Antibodies; Xenogeneic Antibodies; Xenogenic Antibodies; Antibodies, Heterogenetic; Antibodies, Heterotypic; Antibodies, Xenogeneic; H-D Antibodies; Hanganutziu-Deicher Antibodies; Heteroantibodies; Heterologous Antibodies; P-B Antibodies; Paul-Bunnell Antibodies; Xenoantibodies

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins

Proteins: 58433

Blood Proteins: 3862

Serum Globulins: 74

Immunoglobulins: 20136

Antibodies: 77322

Heterophile Antibodies: 240

Immunoproteins: 30

Immunoglobulins: 20136

Antibodies: 77322

Heterophile Antibodies: 240

Globulins: 305

Serum Globulins: 74

Immunoglobulins: 20136

Antibodies: 77322

Heterophile Antibodies: 240

Experts

1.	Ruiz Ginés, Juan-Antonio: 1 article (02/2008)
2.	Raigal Martín, José María: 1 article (02/2008)
3.	Ruiz Ginés, Miguel-Angel: 1 article (02/2008)
4.	Raigal Martín, María Yolanda: 1 article (02/2008)
5.	Giovanella, Luca: 1 article (10/2007)
6.	Ghelfo, Antonella: 1 article (10/2007)
7.	Duk, Maria: 1 article (01/2003)
8.	Kościelak, Jerzy: 1 article (01/2003)
9.	Gołaszewska, Ewa: 1 article (01/2003)
10.	Kurowska, Ewa: 1 article (01/2003)

Related Diseases

1.	Thrombocytopenia (Thrombopenia) 04/08/1988 - "Experimental animal studies confirmed the in vitro anti-aggregatory efficacy of SC 38249, since significant inhibitory activity was observed against Paf-acether and ADP-induced responses in dog PRP ex vivo, anti-Forssman antibody-induced thrombocytopenia in anaesthetized guinea pigs, and collagen-induced intravascular aggregation in anaesthetized rabbits. " Order ALL the reference details at left...
2.	Glomerulonephritis 01/01/1990 - "The clearance of heterologous antibodies in experimental antibasement membrane antibody mediated glomerulonephritis." 01/01/1999 - "Crescentic glomerulonephritis can be induced in rodents by injection of heterologous antibodies against the glomerular basement membrane. " 01/01/2001 - "There is evidence that crescentic glomerulonephritis initiated in rodents by heterologous antibodies against the glomerular basement membrane (anti-GBM glomerulonephritis) depends on a Th1-type immune reaction. " 10/01/1989 - "An induction of serious renal damage in experimental glomerulonephritis demands a chronic supply of antigen, rarely seen in human glomerulonephritis; or the use of heterologous antibodies, a design with questionable clinical relevance; or immuno- and nephrotoxic chemicals; or Freund's adjuvant which is also nephrotoxic. " 01/02/1988 - "Renal biopsy specimens from patients with various glomerular disorders were examined by indirect immunofluorescence microscopy with three different heterologous antibodies directed against cytomegalovirus and two heterologous antibodies against herpes simplex virus (HSV) type 1. All 31 samples from patients with immunoglobulin-A (IgA) nephropathy, 1 of 12 with systemic lupus erythematosus (SLE), and 1 of 5 with Henoch-Schönlein purpura (HSP) showed mesangial staining with cytomegalovirus antiserum, whereas no sample from 37 patients with other forms of glomerulonephritis was positive. " Order ALL the reference details at left...
3.	Infectious Mononucleosis (Glandular Fever) 04/01/2009 - "The aim of this study was to evaluate the sensitivity and the specificity of a rapid test detecting heterophil antibodies in diagnosing infectious mononucleosis in a paediatric population. " 11/01/1990 - "The purpose of this study was to compare not only the two different test systems but also the two different methods they represent for accuracy in detecting infectious mononucleosis-specific heterophil antibodies. " 11/01/1990 - "The present study evaluated the Ventrescreen Mono enzyme immunoassay (Ventrex Laboratories) and Monolatex (Wampole Laboratories) for detection of infectious mononucleosis-specific heterophil antibodies by comparing test results on sera of 247 symptomatic patients. " 12/01/1977 - "Studies on the heterophile antibodies of infectious mononucleosis. " 03/01/2006 - "Paul Bunnell Davidson test, although non-specific, is still in use today in diagnosis of infectious mononucleosis and for detection of heterophile antibodies. " Order ALL the reference details at left...
4.	Infection 10/01/1958 - "Studies on the heterophile antibodies associated with helminth infections. " 07/01/1958 - "Studies on the heterophile antibodies associated with helminth infections. " 01/01/1958 - "Studies on the heterophile antibodies associated with helminth infections. " 01/01/1991 - "These considerations lead us to state some directions for future researches: exact mechanisms of the different virus development stages within their vectors and type of their genetical control, defense reactions of arthropods and pathogenic effects of the viral infection, possible interference with other micro-organisms or with homologous or heterologous antibodies,.. " 01/01/1985 - "Characteristics of the anti-sheep red blood cell heterophile antibodies produced during Schistosoma japonicum infection in mice." Order ALL the reference details at left...
5.	Melanoma (Melanoma, Malignant) 08/01/2003 - "Immunohistochemical staining with anti-LMP2 and anti-LMP7 xenoantibodies showed a significantly higher expression of these immunoproteasome subunits in primary melanoma lesions exhibiting histological signs of tumour regression than in primary melanoma lesions without regression phenomena. " 01/01/1994 - "The aim of this study was to detect possible immunomodulatory effects of unpurified human alpha-interferon on izohemagglutinin (IZO), and anti-Forssman antibody (AFA) serum levels during a treatment in patients with malignant melanoma. " 02/01/1984 - "Quantities of a 100,000-mol wt human melanoma-associated antigen (MAA), defined by both monoclonal and polyclonal xenoantibodies, were measured in sera of 32 patients with malignant melanoma and 15 carefully documented healthy volunteers by use of an amplified sandwich enzyme-linked immunoabsorbent assay. " 02/01/1981 - "Lysis of cultured human melanoma M10 cells by polyclonal xenoantibodies to melanoma-associated antigens." 03/01/1977 - "These antigens injected into rabbits produced xenoantibodies which after absorption with melanoma cells became specific to B cell antigens. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Platelet Activating Factor
2.	Collagen
3.	Adenosine Diphosphate (ADP)
4.	1- (2,3- bis((4- methoxyphenyl)methoxy)propyl)- 1H- imidazole
5.	Antigens
6.	Antibodies
7.	Immunoglobulin G (IgG)
8.	Immunoglobulin M (IgM)
9.	Antigen-Antibody Complex (Immune Complex)
10.	Anti-Idiotypic Antibodies

Related Therapies and Procedures

1.	Transplantation (Transplant Recipients)
2.	Transplants (Transplant)
3.	Injections
4.	Heterologous Transplantation (Xenotransplantation)
5.	Subcutaneous Injections

Best Treatments:
Research Summary Report
on Thrombocytopenia

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 615 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>